News in FLASH Radiotherapy

First randomised Phase II trial using FLASH radiotherapy for NMSC

First randomised Phase II trial using FLASH radiotherapy for nonmelanoma skin cancer (NMSC) treatment

May 2023
Source: Clinical Trials Arena

Use X-ray spectroscopy to explain why FLASH cancer therapy is effective

Researchers use X-ray spectroscopy to explain why FLASH cancer therapy is so effective

July 2023
Source: American Crystallographic Association & Science X Network

FLASH irradiation spares immune cells during proton therapy

FLASH irradiation spares immune cells during proton therapy

Jan 2024
Source: Physics World

How FLASH Radiotherapy Works

Ultra-high dose rate radiation therapy (FLASH-RT) exhibits the ability to effectively eliminate tumour cells to the same extent as conventional dose rate radiation while preserving neighbouring healthy tissues.

FLASH-RT is administered at a rate of 40 Gy/second or more — or 1000 times the dose rate of conventional photon radiotherapy. This means that radiation doses typically administered to tumours over a span of several minutes can now be delivered within milliseconds.

exposed to neutrons

Sparing of healthy tissues has been validated across various radiation modalities (X-ray, electron, proton) and in experiments involving cells, tissues, and animal models. The molecular mechanisms involved are under investigation.

About NorFLASH

  • Mission

    The Norwegian FLASH Radiotherapy Network (NorFLASH) is a non-profit, multidisciplinary professional association. NorFLASH is committed to advancing FLASH radiation therapy (FLASH-RT).
  • Purpose and Objectives

    NorFLASH's purpose is to help develop FLASH-RT in various scientific areas and brings together professionals from different fields. Scientific areas of focus include medical physics, biophysics, radiobiology, radiology, radiochemistry, medical device instrumentation, and clinical applications.

    NorFLASH facilitates disseminating accurate scientific information about FLASH-RT, raising awareness of research findings, establishing connections with other professional societies and relevant international organisations, and undertaking other initiatives as deemed appropriate to advance the field. 
  • Global Collaboration and Networking

    NorFLASH fosters communication and collaboration among scientists and individuals worldwide engaged in FLASH-RT-related activities.

    NorFLASH aims to establish connections with other professional societies and relevant international organisations to enhance collaboration and knowledge-sharing.
  • Initiatives

    NorFLASH undertakes various initiatives as deemed appropriate to advance the field of FLASH-RT. These initiatives may include organising events, conferences, and activities that contribute to the growth and development of FLASH-RT.

    NorFLASH serves as a hub for professionals involved in FLASH-RT, promoting collaboration, disseminating information, and contributing to the advancement of FLASH-RT in the global scientific community.

NorFLASH Membership

NorFLASH aims to promote the progress of science by facilitating interactions and cooperation between related fields. If you wish to become a member, please contact the secretariat (e-mail : post@flashrt.center).

Membership Categories

  • Regular Member
    An individual who conducts research that aligns with the objectives of NorFLASH.
  • Supporting Member 
    An individual or a group that shares the objectives of NorFLASH and provides financial support for NorFLASH's activities.
  • Honorary Member
    An individual who has made distinguished contributions to NorFLASH. Honorary membership is recommended by the executive committee of NorFLASH and is approved in a general meeting.

Get in Touch

Please leave a message using the form below.

Offices

Bergen

Tromsø

Norwegian FLASH Radiotherapy Network (NorFLASH)

c/o yfch@hvl.no (NorFLASH secretariat)
Western Norway University of Applied Sciences
Inndalsveien 28, 5063 Bergen, Norway
e-mail : post@flashrt.center

Ultra-high dose rate radiation therapy (FLASH-RT) (40 Gy/second or more) exhibits the ability to effectively eliminate tumour cells to the same extent as conventional dose rate radiation while preserving neighbouring healthy tissues. Sparing of healthy tissues has been validated across various radiation modalities (X-ray, electron, proton) and in experiments involving cells, tissues, and animal models. The molecular mechanisms involved are under investigation.

The Norwegian FLASH Radiotherapy Network (NorFLASH) fosters communication and collaboration among scientists and individuals worldwide engaged in FLASH-RT-related activities. NorFLASH serves as a hub for professionals involved in FLASH-RT, promoting collaboration, disseminating information, and contributing to the advancement of FLASH-RT in the global scientific community.

If you wish to become a member, please contact the secretariat. e-mail : post@flashrt.center